Compare NRC & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | SAR |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 390.8M | 360.3M |
| IPO Year | 1997 | N/A |
| Metric | NRC | SAR |
|---|---|---|
| Price | $18.78 | $21.88 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $23.75 |
| AVG Volume (30 Days) | 87.6K | ★ 102.5K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | 3.86% | ★ 14.34% |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.39 |
| P/E Ratio | $133.93 | ★ $9.44 |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $11.01 | $20.78 |
| 52 Week High | $22.79 | $25.64 |
| Indicator | NRC | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 62.43 | 40.68 |
| Support Level | $14.76 | $21.40 |
| Resistance Level | $19.39 | $23.74 |
| Average True Range (ATR) | 0.97 | 0.47 |
| MACD | 0.15 | -0.12 |
| Stochastic Oscillator | 91.30 | 2.33 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.